Private healthcare market in Central Europe 2013 Development forecasts for 2013-2015

Private healthcare market in Central Europe 2013

Development forecasts for 2013-2015

This publication explores the market for private health insurance and medical subscriptions in Poland, the Czech Republic, Hungary, Romania, Bulgaria and Slovakia.

 

It evaluates current conditions, key events and influential trends affecting growth and development and offers in depth forecasts for the period 2013-2015

 

Patient preferences, the medical tourism sector and the consequences of the Patients without borders directive are examined in terms of impact on the market, and leading health care services companies are introduced using detailed corporate profiles.

 

Core market information includes

  • Market data illustrating value, growth and structure over the years 2009-2014
  • Expected outcomes of important trends and events in the market during the period 2012-2015
  • In-depth analysis of the health insurance segment of the overall Central European market
  • Examination of the medical subscriptions segment in CE
  • Current status and future prospects for private hospitals in Central Europe
  • Conditions and outlooks for the dental and dialysis segments 
  • Analysis of the regulatory environment and upcoming changes.

 

Did you know...

  • In 2012 and early 2013, key private healthcare companies in Poland continued to expand their chains of facilities.
  • In the last five years, the Czech healthcare market has been relatively stable.
  • In Bulgaria the main factor which affects private healthcare spending, mainly in the long term, is real GDP.
  • Less substantial growth in the value of the market is expected in Romania in 2013.
  • The Romanian private healthcare industry has developed considerably over the last few years.

 

Unique insights of the report include

  • Corporate profiles that cover market leaders in even greater detail than before
  • Analysis of both the health insurance and private hospitals segments of the Central European market
  • Insightful forecasts for each of the countries covered in this report.

 

Selected companies analysed in this report

 

Agel,  Allianz,  Astra, Buda Health Centre, Bulgaria Zdrave ZOK, Bupa International, Euroclinicum, Euromedic, Falck, Generali, Grupa Nowy Szpital, InterRisk, LUX MED Group, Magodent, Medicover, MedLife, Polisano, Regina Maria, Signal Iduna, Swissmed, Tokuda, Uniqa.

 

This report addresses key questions that advance your market knowledge

  • Which factors can negatively affect investment in each of the Central European countries: Poland, the Czech Republic, Hungary, Romania, Bulgaria and Slovakia?
  • Which segment, private health insurance or medical subscription, offers greater investment potential for the next few years?
  • How each market segment is faring currently, and what changes are expected by 2015?
  • What is the regulatory outlook for private healthcare in each of the covered countries? How will the implementation of changes affect growth and performance?

 

This document has proven to be an incomparable asset to professionals when

  • Establishing new private healthcare operations
  • Planning strategy
  • Keeping track of the competition
  • Monitoring market developments
  • Assessing the market’s potential for growth
  • Forecasting future conditions in CE markets.

 

The market intelligence in this report is especially sought-after by

  • Providers of private health insurance and medical subscriptions
  • Private madical companies
  • Consultants, researchers and analysts
  • Academic and government institutions
  • Trade, industry and commerce professionals.
  • A wide range of financial services providers.

 

Extract from this report

  • The overall market in the six countries covered by this study increased by 21% between 2009 and 2012, from €4.9bn to €5.9bn. This happened despite the decline in euro terms in 2009 which was caused by the global financial crisis and the reduction in patient purchasing power.
  • There was a slight slow down in 2012 due to the worse macroeconomic conditions. All in all, the market will be slowly recovering from crisis, but will not generate record double-digit growths similar to those before 2008, despite some improvements in legal conditions in some countries (however not crucial, e.g. no competition in the area of compulsory insurance is planned in the countries in which it has not been implemented yet).
  • The growth of fee-for-services have the largest impact here and this will not be impressive in 2013-2015 due to the still not the best macroeconomic situation. 

Market commentary by expert

 

The CE countries are facing various problems in their healthcare industries, including a shortage of public funds for healthcare services, the emigration of healthcare professionals, inequalities in access to healthcare services and limited access to specialist treatment. This obviously influences also the private sector by stimulating or hampering its development. In the report we have examined and described thoroughly the influence of those and other factors on the private healthcare market value. Future forecasts presented for the years 2013-2015 also take such factors into account, as well as macroeconomic indicators.

 

Monika stefańczyk, Haad Pharma & Healthcare market Analyst

 

It's a great pleasure to cooperate with PMR because of its analysts' wealth of experience in understanding the local market. We consider PMR a competent and professional company which helps us conduct our business. I would also like to state that PMR's team is always ready to respond to emerging customer needs. We can recommend it as a reliable partner. Business Analyst, Hilti Distribution, Russia
We use PMR's services due to their analysts' extensive experience in market analysis, their high quality and level of engagement in the market research carried out for us. We consider PMR a competent and professional company and recommend them as a reliable partner in the area of economic information and market analysis. Senior Trade and Investment Adviser, British Embassy in Warsaw
PMR provides a good service and is always open to discussion. All reports are well structured & are always on time. Member of the Managment Board, SCA Hygiene Products
Sanofi-Aventis group regularly order PMR's reports and newsletters concerning the Polish pharmaceutical market. We use PMR's services because of the wealth of experience of its analysts in undertaking market analysis and a high level of quality and involvement in the field of market research. General Manager, Sanofi-Synthelabo
PMR reports are a serious contribution to the market overview picture, focusing our attention on key events in the industry as well as highlighting both general and specific market indicators. Together, these components are the base for our future forecasts of construction market development and help us to plan our sales. Market Analyst, Alpha Cement
As a London-based company, with operations abroad, we looked for the best-in-class Market Intelligence supplier. PMR brought us quality reports that improved our CEE market knowledge and understanding. Development Manager, GVA Grimley
PMR's analysts understand our needs well and the standard of their service has always fully met our expectations. We are looking forward to cooperating with PMR in the future as well. Senior Trade and Investment Adviser, British Embassy in Warsaw
We consider PMR a competent and professional company. PMR analysts understand our needs clearly and their services have fully met our expectations. I strongly recommend the company as a reliable partner in providing economic information and market analysis. General Manager, Sanofi-Synthelabo

  1. Report methodology p. 15

  2. Executive summary p. 21

  3. Overview of the private healthcare market in CE p. 27

    1. Most serious problems in healthcare p. 27
      1. Poland p.   27
      2. Czech Republic p. 27
      3. Slovakia p.   28
      4. Bulgaria p. 28
      5. Romania   p. 28
      6. Hungary p. 28
    2. Major trends and events in CE region p. 29
      1. Poor healthcare infrastructure p. 29
      2. Hospital reform p. 31
      3. Health insurance provisions p. 32
      4. Human resources p. 33
    3. Private hospitals p. 36
      1. Patients Without Borders Directive p.   36
    4. Market size and development forecasts, 2009-2015 p. 37
  4. Reforms and trends in CE countries p. 39

    1. Poland p. 39
      1. Key reforms and trends until 2013 p. 39
      2. Predicted reforms and trends (2013-2015) p. 43
    2. Czech Republic p. 45
      1. Key reforms and trends until 2013 p. 45
      2. Predicted reforms and trends (2013-2015) p. 51
    3. Slovakia p. 52
      1. Key reforms and trends until 2013 p. 52
      2. Predicted reforms and trends (2013-2015) p. 54
    4. Bulgaria p. 56
      1. Key reforms and trends until 2013 p. 56
      2. Predicted reforms and trends (2013-2015) p. 58
    5. Romania p. 59
      1. Key reforms and trends until 2013 p. 59
      2. Predicted reforms and trends (2013-2015) p. 65
    6. Hungary p. 66
      1. Key reforms and trends until 2012 p. 66
      2. Predicted reforms and trends (2013-2015) p. 69
  5. Overall private healthcare market p. 71

    1. Poland p. 71
      1. General characteristics and market value p. 71
      2. Selected key players p. 73
      3. Recent and planned investments p. 103
    2. Czech Republic p. 105
      1. General characteristics and market value p. 105
      2. Selected key players p. 106
    3. Slovakia p. 114
      1. General characteristics and market value p. 114
      2. Selected key players p. 116
      3. Recent and planned investments p. 119
    4. Bulgaria p. 119
      1. General characteristics and market value p. 119
      2. Selected key players p. 121
      3. Recent and planned investments p. 123
    5. Romania p. 123
      1. General characteristics and market value p. 123
      2. Selected key players p. 125
      3. Recent and planned investments p. 137
    6. Hungary p. 139
      1. General characteristics and market value p. 139
      2. Selected key players p. 141
      3. Planned investments p. 146
  6. Medical subscriptions market p. 147

    1. Poland p. 147
    2. Czech Republic p. 149
    3. Slovakia p. 149
    4. Bulgaria p. 149
    5. Romania p. 150
    6. Hungary p. 150
  7. Health insurance market p. 151

    1. Poland p. 151
      1. Overview p. 151
      2. Legal developments p. 154
      3. Market value p. 155
      4. Selected key players p. 157
    2. Czech Republic p. 163
      1. Overview p. 163
      2. Legal developments p. 163
      3. Market value p. 164
        1. Compulsory health insurance p. 164
        2. Voluntary health insurance p. 164
      4. Selected key players p. 165
    3. Slovakia p. 169
      1. Overview p. 169
      2. Legal developments p. 170
      3. Market value p. 171
        1. Compulsory health insurance p. 171
        2. Voluntary health insurance p. 172
      4. Selected key players p. 172
    4. Bulgaria p. 175
      1. Legal developments p. 175
      2. Market value p. 176
        1. Voluntary health insurance p. 176
        2. Health insurance as part of life insurance p. 178
      3. Main players in voluntary health insurance p. 179
      4. Main life insurance companies which offer health insurance p. 187
    5. Romania p. 196
      1. Overview p. 196
      2. Legal developments p. 196
      3. Market value p. 196
      4. Selected key players p. 199
    6. Hungary p. 208
      1. Overview p. 208
      2. Legal developments p. 208
      3. Market value p. 210
      4. Selected key players p. 213
  8. Private hospitals p. 221

    1. Poland p. 221
      1. Major past events and trends p.   221
      2. Number and characteristics of establishments p. 224
      3. Establishment of new non-public hospitals prior to 2013 p. 224
      4. Expected events and trends p.   226
      5. Planned establishment of new non-public hospitals p. 228
      6. Profiles of selected hospitals and hospital groups p. 229
    2. Czech Republic p. 232
      1. Major past events and trends p. 232
      2. Number and characteristics of establishments p. 234
      3. Establishment of new non-public hospitals prior to 2013 p. 234
      4. Expected events and trends p. 235
      5. Profiles of selected hospitals and hospital groups p. 236
    3. Slovakia p. 239
      1. Major past events and trends p. 239
      2. Number and characteristics of establishments p. 240
      3. Establishment of new non-public hospitals prior to 2013 p. 240
      4. Expected events and trends p. 241
      5. Planned establishment of new non-public hospitals p. 241
      6. Profiles of selected hospitals and hospital groups p. 242
    4. Bulgaria p. 245
      1. Major past events and trends p. 245
        1. Mortality at private hospitals p. 245
        2. National Health Map p. 245
        3. Municipal hospitals rendered bankrupt p. 246
      2. Number and characteristics of establishments p. 246
      3. Establishment of new non-public hospitals prior to 2013 p. 246
      4. Expected events and trends p. 247
      5. Planned establishment of new non-public hospitals p. 249
      6. Profiles of selected hospitals and hospital groups p. 250
    5. Romania p. 255
      1. Major past events and trends      255
      2. Number and characteristics of establishments p. 256
      3. Establishment of new non-public hospitals prior to 2013 p. 257
      4. Expected events and trends p. 259
      5. Planned establishment of new non-public hospitals p. 260
      6. Profiles of selected hospitals and hospital groups p. 260
    6. Hungary p. 261
      1. Major past events and trends p. 261
      2. Number and characteristics of establishments p. 262
      3. Establishment of new non-public hospitals prior to 2013 p. 263
      4. Expected events and trends p. 263
      5. Profiles of selected hospitals and hospital groups p. 264
  9. Other areas of private healthcare p. 267

    1. Dialysis p. 267
      1. Poland p. 267
      2. Czech Republic p. 269
      3. Slovakia p. 270
      4. Bulgaria p. 271
      5. Romania p. 272
      6. Hungary p. 274
    2. Stem cells p. 275
      1. Poland p. 275
      2. Czech Republic p. 276
      3. Slovakia p. 276
      4. Bulgaria p. 277
      5. Romania p. 277
      6. Hungary p. 279
    3. Infertility treatment p. 279
      1. Poland p. 279
      2. Czech Republic p. 280
      3. Slovakia p. 280
      4. Bulgaria p. 281
  10. Consumer behaviour and social trends p. 283

    1. Corruption and informal payments p. 283
    2. Ageing population p. 284
    3. Growing spending power p. 286
    4. Medical tourism p. 288
      1. Poland p. 288
      2. Czech Republic p.   289
      3. Slovakia p. 290
      4. Bulgaria p. 291
      5. Romania p. 291
      6. Hungary p. 292
    5. Attitudes towards private healthcare p. 293
      1. Poland p.   293
        1. Assessment of healthcare system p. 293
        2. Most frequent fringe benefits offered by employers p.   293
        3. Financial barriers in the access to private healthcare p. 295
      2. Czech Republic p. 296
        1. Assessment of recent or planned reforms p. 296
      3. Slovakia p. 296
        1. Assessment of healthcare system p. 296
      4. Romania p. 296
        1. Assessment of healthcare system p. 296
        2. Frequency of use of private healthcare p. 297
        3. Profiles of private healthcare users p. 297
        4. Brand recognition p. 297
        5. Additional and informal payments p. 297
      5. Hungary p. 298
        1. Spending on healthcare p. 298
        2. Reasons for choosing private health service p. 298
        3. Assessment of private healthcare p. 299
        4. Frequency of use of private healthcare p. 299
        5. Profiles of private healthcare users p. 299
  11. Economic trends in CE p. 301

    1. Total health spending p. 301
    2. Public spending p. 302
      1. Public spending by service category: country focus p. 303
        1. Poland p. 303
        2. Czech Republic p. 304
        3. Slovakia p. 304
        4. Bulgaria p. 305
        5. Romania p. 306
        6. Hungary p.   306
    3. Private sector spending p. 307
  12. List of graphs p. 309

  13. List of tables p. 317

  14. About PMR p. 321

List of graphs

  1. Value (€ bn) and change (%) of the private healthcare market in Central Europe, 2009-2015      24
  2. Average CAGR for development of private healthcare markets in CE countries analysed (%), 2013-2015      25
  3. Number of hospital beds in CE countries analysed, per 1,000 of population, 1995 and 2008-2011      32
  4. Number of doctors leaving Bulgaria, 2008-2012      34
  5. Plans for returning among Hungarian doctors working abroad (%), 2012-2014      35
  6. Value (€ bn) and change (%) of the private healthcare market in Central Europe, 2009-2015      37
  7. Shares of individual countries as a proportion of the private healthcare market value in Central Europe (%), 2009, 2012 and 2015      38
  8. Average CAGR for development of private healthcare markets in CE countries analysed (%), 2013-2015      38
  9. Total number of doctors working in Romanian private healthcare industry and y-o-y change (%), 2011      60
  10. Structure of private healthcare expenditures in Poland (%), 2012      72
  11. Value (€ bn) and change (%) of the private medical services market in Poland, 2009-2015      72
  12. Revenue of the selected top private medical companies in Poland (PLN m), 2012      73
  13. LUX MED Group’s revenue in Poland (€ m) and change (%), 2008-2012      74
  14. Structure of LUX MED Group’s revenue in Poland, by source of funding (%), 2010-2012      75
  15. Medicover Group’s revenue in Poland (€ m) and change (%), 2005-2012      78
  16. Centrum Medyczne Damiana’s revenue in Poland (€ m) and change (%), 2006-2011      78
  17. Enel-Med’s revenue in Poland (€ m) and change (%), 2002-Q1 2013      81
  18. Structure of Enel-Med’s revenue in Poland, by medical divisions (%), 2007-2012      81
  19. Revenue change in Enel-Med’s particular segments in Poland (%), 2012      82
  20. Enel-Med’s revenue from medical subscriptions in Poland (€ m) and change (%), Q1 2012 and Q1 2013      82
  21. EMC Instytut Medyczny Group’s revenue in Poland (€ m) and change (%), 2005-Q1 2005-Q1 2013      85
  22. Falck Medycyna’s revenue and net profit in Poland (€ m), 2006-2011      87
  23. Scanmed Multimedis Group’s sales structure in Poland (%), by operation area, by value, 2012      91
  24. Scanmed Multimedis Group’s sales structure in Poland (%), by customer, by value, 2012      91
  25. Change in sales of commercial services in Scanmed Multimedis Group in Poland (%), 2010-2012      92
  26. Swissmed Group’s revenue in Poland (€ m) and change (%), 2005-2012      95
  27. Swissmed Group’s sales structure in Poland (%), by source of financing, by value, Q2-Q4 2012      96
  28. Revenue of the Swissmed Group from inpatient and outpatient care in Poland (€ m), 2005 – Q1-Q3 2012      96
  29. Structure of Swissmed PSM’s revenue in Poland (%), by medical divisions, Q2 2012-Q1 2013      97
  30. Swissmed PSM’s revenue from medical subscriptions (€ m) and number of procedures (‘000) for subscription patients in Poland, 2009-Q1 2013      97
  31. Polmed Group’s revenue in Poland (€ m) and change (%), 2009-Q1 2013      99
  32. Structure of the Polmed Group’s revenue in Poland, by medical divisions (%), 2009-Q1 2013      100
  33. Polmed Group’s revenue from medical subscriptions in Poland (€ m) and change (%), 2009-Q1 2013      100
  34. Value (€ m) and change (%) of the private medical services market in the Czech Republic, 2009-2015      106
  35. Euromedic’s revenue and net profit in the Czech Republic (€ m), 2008-2011      107
  36. MediClinic’s sales revenue and net loss in the Czech Republic (€ m), 2009-2012      108
  37. Medicon’s sales revenue and net profit/loss in the Czech Republic (€ m), 2007-2012      109
  38. Moje Ambulance’s sales revenue and net profit/loss in the Czech Republic (€ m), 2008-2011      110
  39. Euroclinicum’s sales revenue and net profit/loss in the Czech Republic (€ m), 2007-2011      111
  40. Canadian Medical Care Ceska Republika’s sales revenue and net profit/loss in the Czech Republic (€ m), 2007-2010      111
  41. Kardia’s sales revenue and net profit in the Czech Republic (€ m), 2007-2011      112
  42. Medicover’s sales revenue and net profit/loss in the Czech Republic (€ m), 2008-2011      113
  43. Value (€ m) and change (%) of the private medical services market in Slovakia, 2007-2015      115
  44. Value (€ m) and change (%) of the private medical services market in Bulgaria, 2003-2015      120
  45. Value (€ m) and change (%) of the total private healthcare spending in Bulgaria, 2007-2015      121
  46. Value (€ m) and change (%) of the private medical services market in Romania, 2005-2015      125
  47. Sales increases forecasted for selected private healthcare providers in Romania (%), 2013      126
  48. MedLife’s sales revenues in Romania (€ m) and change (%), 2009-2013      128
  49. Regina Maria’s sales revenues in Romania (€ m) and change (%), 2011-2013      130
  50. Medicover’s net sales revenues and net profit/loss in Romania (€ m) and change (%), 2007-2013      131
  51. Synevo sales revenues and net profit/loss in Romania (€ m) and change (%), 2006-2012      132
  52. Sanador’s net sales revenues and net profit/loss in Romania (€ m), and change (%), 2007-2013      133
  53. Polisano’s sales revenues in Romania (€ m) and change (%), 2007-2011      133
  54. Gral Medical’s sales revenues in Romania (€ m) and change (%), 2007-2013      134
  55. Gral Medical’s net sales revenues and net profit in Romania (€ m), and change (%), 2006-2011      134
  56. Romar’s sales revenues in Romania (€ m) and y-o-y change (%), 2012-2013      136
  57. Value (€ m) and change (%) of the private medical services market in Hungary, 2007-2015      141
  58. Medicover’s revenues and net profit/loss in Hungary (€ m), 2007-2011      145
  59. Value (PLN bn) and change (%) of the medical subscription market in Poland, 2005-2015      148
  60. Profitability of health insurance policies in Poland (%), Q2 2012      152
  61. Number of people having supplementary health insurance in Poland (‘000), 2011-2012      152
  62. Sections chosen by insurance companies for placing health insurance policies in Poland (%), 2013      154
  63. Value (PLN bn) and change (%) of the private health insurance market in Poland, 2009-2015      157
  64. Share of health insurance premiums in the portfolio of insurance companies in Poland (%), Q2 2012      157
  65. Revenue from health insurance premiums in the Czech Republic (CZK bn) and change (%), 2007-2012       164
  66. Expenditure on private health insurance in the Czech Republic (CZK m) and change (%), 2008-2010      164
  67. Pojistovna VZP’s revenue from health insurance premiums in the Czech Republic (€ m) and change (%), 2008-Q1 2013      165
  68. Claims paid by Pojistovna VZP on health insurance in the Czech Republic (€ m) and change (%), 2007-Q1 2013      166
  69. Ceska pojistovna Zdravi’s revenue from health insurance premiums in the Czech Republic (€ m) and change (%), 2007-2012      167
  70. Claims paid by Ceska pojistovna Zdravi on health insurance in the Czech Republic (€ m) and change (%), 2007-2012      167
  71. Union’s revenue from health insurance premiums in Slovakia (€ m) and change (%), 2007-2011      174
  72. Total healthcare expenditure of Union in Slovakia (€ m) and change (%), 2007-2011      174
  73. Revenue from premiums charged by voluntary health insurance companies in Bulgaria (BGN m) and change (%), 2002-Q1 2013      177
  74. Premiums charged by voluntary health insurance companies in Bulgaria, by category of healthcare service, 2012-Q1 2013      178
  75. Premiums charged by life insurance companies for health insurance in Bulgaria (BGN m) and change (%), 2003-Q1 2013      179
  76. Voluntary health insurers in Bulgaria, by share of revenue from health premiums (%), 2012-Q1 2013      180
  77. UHIF Doverie’s revenue from health insurance premiums in Bulgaria (€ m) and change (%), 2007-Q1 2013      181
  78. Claims paid by UHIF Doverie on health insurance in Bulgaria (€ m) and change (%), 2007-Q1 2013      182
  79. Bulgaria Zdrave’s revenue from health insurance premiums in Bulgaria (€ m) and change (%), 2007-Q1 2013      183
  80. Claims paid by Bulgaria Zdrave on health insurance in Bulgaria (€ m) and change (%), 2007-Q1 2013      183
  81. Generali Zakrila’s revenue from health insurance premiums in Bulgaria (€ m) and change (%), 2007-Q1 2013      184
  82. Claims paid by Generali Zakrila on health insurance in Bulgaria (€ m) and change (%), 2007-Q1 2013      185
  83. Euroins-Health Assurance’s revenue from health insurance premiums in Bulgaria (€ m) and change (%), 2008-Q1 2013      186
  84. Claims paid by Euroins-Health Assurance on health insurance in Bulgaria (€ m) and change (%), 2008-Q1 2013      186
  85. Life insurance companies which offer health insurance in Bulgaria, by share of revenue from premiums (%), 2011-Q1 2013      188
  86. Generali Life’s revenue from health insurance premiums in Bulgaria (€) and change (%), 2007-Q1 2013      189
  87. Claims paid by Generali Life on health insurance in Bulgaria (€) and change (%), 2007-Q1 2013      189
  88. Bulstrad Life’s revenue from health insurance premiums in Bulgaria (€) and change (%), 2007-Q1 2013      190
  89. Claims paid by Bulstrad Life on health insurance in Bulgaria (€) and change (%), 2007-Q1 2013      191
  90. DZI’s revenue from health insurance premiums in Bulgaria (€) and change (%), 2007-Q1 2013      192
  91. Claims paid by DZI on health insurance in Bulgaria (€) and change (%), 2007-Q1 2013      192
  92. Uniqa Life’s revenue from health insurance premiums in Bulgaria (€ m) and change (%), 2007-2012      193
  93. Claims paid by Uniqa Life on health insurance in Bulgaria (€) and change (%), 2007-2012      194
  94. Allianz Life’s revenue from health insurance premiums in Bulgaria (€) and change (%), 2009-2012      195
  95. Claims paid by Allianz Life’s on health insurance in Bulgaria (€) and change (%), 2010-2012      195
  96. Value (€ m) and change (%) of the health insurance market in Romania, 2006-Q1 2013      198
  97. Value (€ m) and change (%) of the non-life health insurance market in Romania, 2006-Q1 2013      198
  98. Value (€ m) and change (%) of the life health insurance market in Romania, 2006-Q1 2013      199
  99. Astra’s revenue from health insurance premiums in Romania (€ m), 2009-2012      201
  100. Claims paid by Astra on health insurance in Romania (€ ’000) and change (%), 2006-2011      201
  101. Eureko’s revenue from health insurance premiums in Romania (€ m) and change (%), 2006-H1 2012      202
  102. Claims paid by Eureko on health insurance in Romania (€ m) and change (%), 2006-2011      203
  103. BCR’s revenue from health insurance premiums in Romania (€ m) and change (%), 2010-2011      204
  104. AXA Life’s revenue from health insurance premiums in Romania (€ m) and change (%), 2006-2011      205
  105. Claims paid by AXA Life on health insurance in Romania (€ ’000) and change (%), 2007-2011      205
  106. Signal Iduna’s revenue from health insurance premiums in Romania (€ m) and change (%), 2008-2011      206
  107. Claims paid by Signal Iduna on health insurance in Romania (€ ’000) and change (%), 2009-2011       207
  108. Value (HUF bn) and change (%) of the voluntary health insurance market in Hungary, 2005-2012      212
  109. Revenues from healthcare fund market in Hungary (HUF m) and change (%), 2009-2012      212
  110. Number of private voluntary health insurance policy holders in Hungary and change (%), 2005-2012      213
  111. Market shares of voluntary health insurance companies in Hungary (%), in terms of value, 2011      213
  112. Number of MKB’s voluntary health insurance policy holders in Hungary and change (%), 2005-2013      214
  113. Value of assets collected by MKB from voluntary health insurance in Hungary (€ m) and change (%), 2005-2012      214
  114. Number of OTP’s voluntary health insurance policy holders in Hungary and change (%), 2005-2011      215
  115. Value of assets collected by OTP from voluntary health insurance in Hungary (€ m) and change (%), 2005-2011      215
  116. Number of AXA voluntary health insurance policy holders in Hungary and change (%), 2005-2011      216
  117. Value of assets collected by AXA from voluntary health insurance in Hungary (€ m) and change (%), 2005-2011      216
  118. Number of Patika’s voluntary health insurance policy holders in Hungary and change (%), 2005-2012      217
  119. Value of assets collected by Patika from voluntary health insurance in Hungary (€ m) and change (%), 2005-2012      218
  120. Patika revenues and cost of services in Hungary (HUF bn), 2008-2012      218
  121. Number of Generali’s voluntary health insurance policy holders in Hungary and change (%), 2005-2012      219
  122. Value of assets collected by Generali from voluntary health insurance in Hungary (€ m) and change (%), 2005-2012      220
  123. Average cost of hospital stays in the area of ophthalmology at public and non-public facilities in Poland (PLN), 2009-2011      222
  124. Number of public and non-public subjects with contracts for hospital treatment in the area of ophthalmology in Poland, 2009-2011      222
  125. Average cost of hospital stays at public and non-public facilities in Poland (PLN), 2009-2011      223
  126. Karlovarska krajska nemocnice’s sales revenue and net profit/loss in Czech Republic (€ m), 2007-2012      238
  127. Financial results of Nemocnica Kosice-Saca in Slovakia (€ m), 2007-2010      244
  128. Revenues from medical services of Tokuda Hospital in Bulgaria (€ m), 2006-2011      251
  129. Number of hospitals in Romania, 2009 and 2011      257
  130. Non-public dialysis centres in Poland (number of establishments), April 2013      268
  131. Share of public and private dialysis centres in the Czech Republic (number of establishments), end of 2012      269
  132. Share of public and private dialysis centres in Slovakia (%), July 2013      270
  133. Non-public dialysis centres in Slovakia (number of establishments), July 2013      270
  134. Share of public and private dialysis centres in Romania, 2010-2011      272
  135. Share of public and private dialysis patients in Romania, 2010-2011      272
  136. Largest dialysis centres in Romania, by number of facilities, 2010-2011      273
  137. Largest dialysis centres in Romania, by number of patients dialysed, 2010-2011      273
  138. Non-public dialysis centres in Hungary (number of establishments), June 2013      274
  139. Corruption Perception Index in the CE countries analysed, 2001-2012      284
  140. Foreigners treated in Poland, by country of origin (%), 2012      288
  141. Number of foreigners treated at hospitals in the Czech Republic, by country of origin (%), 2012      290
  142. Percentage of Poles satisfied with the healthcare system (%), broken down by users of private and public health care, 2012      293
  143. Most frequent fringe benefits offered by employers in Poland (%), 2012      293
  144. Most frequent healthcare services offered by employers to senior specialists in Poland (%), 2012      294
  145. Most desired fringe benefits in Poland (%), 2012      294
  146. Proportion of people who were forced to give up healthcare services for financial reasons in Poland, selected Western Union countries and United States (%), 2009-2012      295
  147. Reasons for choosing private health service providers by VHI holders* in Hungary (%), June 2012      298
  148. Health insurance fund spending in Poland (% of total fund spending), by category, 2011-2013      303
  149. Healthcare spending as % of public health insurance funds in the Czech Republic, by category, 2000-2011      304
  150. Healthcare spending as % of public health spending in Slovakia, by category, 2006-2010      304
  151. NHIF spending by category as % of total spending in Bulgaria, 2012-2013      305

List of tables

  1. Key trends and events in the CE countries analysed, mid-2012–mid-2013      22
  2. Trends and events expected in CE countries analysed, 2013-2015      23
  3. Number of hospitals in CE countries analysed, by category of ownership, beginning of 2013      36
  4. Selected mergers and acquisitions in the private healthcare sector in Poland, 2012-May 2013      40
  5. Healthcare projects under PPP subject to the MRR’s assessment in Poland, 2013      41
  6. Number of employees at private healthcare facilities in the Czech Republic, by category of employee, 2008-2011      47
  7. Number of doctors at healthcare facilities in the Czech Republic, by founding entity, 2008-2011      47
  8. Number of contract workers at private healthcare facilities in the Czech Republic, by category of employee, 2008-2011      48
  9. Average monthly wages of employees at private hospitals in the Czech Republic (CZK), by category of employee, 2008-2011      48
  10. Number of private physicians in Romania, by specialisation, 2009 and 2011      61
  11. Number of healthcare facilities in Romania, by category of ownership, 2005-2011      63
  12. Other healthcare facilities in Romania, by category of ownership, 2009 and 2011      64
  13. New selected proposals which would modify healthcare and health insurance laws in Hungary, April 2013      70
  14. Number of outpatient clinics and hospitals owned by the selected top private medical companies in Poland, April 2013      73
  15. Key information about hospitals operated by EMC Instytut Medyczny in Poland, 2013      84
  16. Revenue and net profit of particular companies controlled by the EMC Instytut Medyczny Group (€ ‘000), 2012      85
  17. PCZ Group’s revenue and net profit in Poland (€ m), 2009-2014      88
  18. Scanmed Multimedis’ revenue in Poland (€ m) and change (%), 2010-2014      91
  19. Other major private medical services companies in Poland, 2013      102
  20. Facilities opened by selected private healthcare companies in Poland, 2012-April 2013      103
  21. Selected planned investments in private outpatient clinics in Poland, 2013      104
  22. Financial results of Medirex companies (€ m), 2007-2011      116
  23. Senior – Geriatricke centrum’s sales revenues and net profit/loss in Slovakia (€ m), 2010-2011      116
  24. Selected other major private medical services companies in Slovakia, 2013      118
  25. Euromedic’s sales revenues and net profit/loss in Bulgaria (€ m) and change (%), 2010-2011      122
  26. Selected other major private medical services companies in Bulgaria, 2013      122
  27. Selected largest private medical companies in Romania, in terms of sales revenues (€ m), 2010-2012      125
  28. Key information about hospitals operated by MedLife in Romania, 2013      127
  29. Key information about hospitals operated by Regina Maria in Romania, 2013      129
  30. Selected other major private medical services companies in Romania, 2012      136
  31. Buda Health Centre’s sales revenues and net profit/loss in Hungary (€ m), 2007-2011      141
  32. Euromedic’s revenues and net profit/loss in Hungary (€ m), 2007-2011      142
  33. Fonix-Med’s revenues and net profit/loss in Hungary (€ m), 2007-2011      143
  34. Other major private medical services companies in Hungary, 2013      146
  35. Other major private insurers which offer health insurance in the Poland, 2013      162
  36. Ceska prumyslova zdravotni pojistovna’s financial results in Czech Republic (CZK ’000), 2011      168
  37. Other major private insurers which offer health insurance in the Czech Republic, 2013      169
  38. Slovak health insurance companies, by number of insurees, 2009-2011      171
  39. Selected major private insurers which offer VHI in Slovakia, 2013      175
  40. Market of private voluntary health insurance in Bulgaria, 2012      178
  41. Selected other prominent voluntary health insurers in Bulgaria, 2013      187
  42. Largest players in the non-life insurance subgroup in Romania, by health insurance gross written premium (RON ‘000), 2011      199
  43. Players in life insurance subgroup in Romania, by health insurance gross written premium (RON ‘000), 2011      200
  44. Selected other major companies which offer health insurance in Romania, 2013      207
  45. Tax allowances available for private healthcare funds in Hungary, as of 1 January 2012      209
  46. Other prominent private insurers which offer health insurance in Hungary, 2013      220
  47. Selected non-public hospitals established in Poland, 2011-2012      225
  48. Selected investment projects planned in non-public hospitals in Poland, 2013-2017      228
  49. Key information about hospitals operated by Grupa Nowy Szpital in Poland, 2013      230
  50. Financial results of Grupa Nowy Szpital’s hospitals in Poland (€ m), 2007-2011      231
  51. Selected expenditures and financial results of Czech hospitals (CZK m), 2012      233
  52. Number of hospitals in the Czech Republic, by category of ownership, 2008-2012      234
  53. Agel’s consolidated revenue and net profit in Czech Republic (€ m), 2007-2011      236
  54. Financial results of selected Agel’s hospitals (€ m), 2006-2012      237
  55. Financial results of selected other largest hospitals in the Czech Republic (€ m), 2004-2011      239
  56. Key information about hospitals operated by Agel in Slovakia, 2013      242
  57. Financial results of selected Agel’s companies (€ m), 2009-2012      243
  58. Key information about hospitals operated by Unipharma in Slovakia, 2013      244
  59. Hospital mortality percentage at private hospital care facilities in Bulgaria, 2010 and 2011      245
  60. Selected private hospitals established in Bulgaria, 2011-2013      247
  61. Selected investment projects planned in non-public hospitals in Bulgaria, 2013-2014      249
  62. Number of beds in selected Sofiamed wards in Bulgaria, May 2013      252
  63. Sofiamed’s sales revenues and net profit/loss in Bulgaria (€ m) and change (%), 2007-2011      253
  64. Financial results of selected other largest hospitals in Bulgaria (€ m), 2007-2011      254
  65. Number of births in selected largest private hospitals in Romania, 2011 – January-May 2012      256
  66. Selected non-public hospitals established in Romania, 2011 and 2012      258
  67. Selected investment projects planned in non-public hospitals in Romania, 2013-2017      260
  68. Financial results of selected other largest hospitals in Romania (€ m), 2005-2011      261
  69. Number of hospitals in Hungary, by owner, 2005-2010      263
  70. Dr. Rose’s sales revenue and net profit/loss in Hungary (€ m), 2008-2012      264
  71. Financial results of selected other largest hospitals in Hungary (€ m), 2004-2011      265
  72. Financial results of selected dialysis centres in Poland (€ m), 2004-2011      269
  73. Fresenius Medical Care Bulgaria’s sales revenues and net profit/loss in Bulgaria (€ m) and change (%), 2007-2011      271
  74. Financial results of selected dialysis stations in Hungary (€ m), 2007-2011      275
  75. Cord Blood Centre’s sales revenue and net profit/loss in the Czech Republic (€ m), 2008-2011      276
  76. Financial results of selected stem cell banks in Bulgaria (€ m), 2010-2011      277
  77. Financial results of selected stem cell banks in Romania (€ m), 2007-2011      278
  78. Krio Institute Cell-Tissue Bank’s sales revenues and net profit/loss in Hungary (€ m) and change (%), 2007-2011      279
  79. Gyncare’s sales revenues and net profit/loss in Slovakia (€ m), 2007-2011      280
  80. Population of the CE countries analysed (‘000 people), 2006-2012      285
  81. Population over 65 years of age and life expectancy at birth in the CE countries analysed, 2011      285
  82. Predictions pertaining to the elderly population, 65 or over, in the CE countries analysed (million people), 2007-2060      285
  83. Average monthly wages in the CE countries analysed (€), 2006-2012      287
  84. Minimum monthly wages in the CE countries analysed (€), 2005-2012      287
  85. Gross National Income per capita in the CE countries analysed ($), 2005-2011      287
  86. Number of foreigners treated at hospitals in the Czech Republic, 2008-2012      289
  87. Invoices for the treatment of foreign patients in Hungary and Hungarians abroad, 2010-2012      292
  88. Total health spending as % of GDP in the CE countries analysed, 2002-2011      302
  89. Public health spending per capita in the CE countries analysed ($ purchasing power parity), 2002-2011      302
  90. Proportion of public and private funds in healthcare expenditures in Poland, 2009-2012      303
  91. Health insurance fund spending by category in Romania (% of total fund spending), 2005-2012      306
  92. Revenues of National Health Insurance Fund in Hungary (HUF m), 2007-2012      306
  93. NHIF spending by category in Hungary (HUF m), 2010-2012      307
  94. Private health spending as % of total health spending in the CE countries analysed, 2002-2011      307
  95. Out-of-pocket spending as % of private health spending in the CE countries analysed, 2002-2011      308
  96. Private prepaid plans as a percentage of private expenditure on health in the selected CE countries analysed, 2002-2011      308